Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02296554 · ClinicalTrials.gov registry record · NA

Superior Labral Tear From Anterior to Posterior (SLAP) Repair Versus Biceps Tenodesis for SLAP Tears in the Shoulder

A NA study, sponsored by HealthPartners Institute.

Terminated
Registry status
NA
Development phase
150
Enrollment target

NCT02296554: Clinical Trial NA study, sponsored by HealthPartners Institute.

NCT02296554 is a NA study that was terminated before completion, run by HealthPartners Institute. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02296554, a NA study, was terminated before completion, sponsored by HealthPartners Institute.

TERMINATED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

Biceps Tenodesis is currently advocated for older, less active patients, but to date is not often advocated for Superior Labral Tear from Anterior to Posterior (SLAP) tears in young, active patients. The ideal surgical management for this pathology is not clearly known. More surgeons are using biceps tenodesis as a treatment for SLAP tears, including in the young, active population. If this study were to demonstrate that biceps tenodesis is similar to or better than SLAP repair, this would fundamentally change the treatment of SLAP tears. Perhaps more importantly, it would likely mean a less involved rehabilitation and earlier return to activities for patients with this pathology.

Primary Outcome

American Shoulder and Elbow Surgeons (ASES)

Interventions

  • PROCEDURE Biceps Tenodesis
  • PROCEDURE SLAP Repair

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2014-06
Est. Completion 2018-12-30
Phase NA
HealthPartners Institute

146 total trials

Why NCT02296554 stopped before completion

NCT02296554 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Biceps Tenodesis is the first listed.

NCT02296554 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02296554 about?

NCT02296554 is a clinical study titled "Superior Labral Tear From Anterior to Posterior (SLAP) Repair Versus Biceps Tenodesis for SLAP Tears in the Shoulder". Biceps Tenodesis is currently advocated for older, less active patients, but to date is not often advocated for Superior Labral Tear from Anterior to Posterior (SLAP) tears in young, active patients. The ideal surgical management for this pathology is not clearly known. More surgeons are using bicep...

What is the current status of trial NCT02296554?

This trial is currently terminated. It is a NA study. The enrollment target is 150 participants. The study started on 2014-06. Estimated completion is 2018-12-30.

What interventions are being tested in trial NCT02296554?

The interventions under investigation include: Biceps Tenodesis (PROCEDURE), SLAP Repair (PROCEDURE).

Who is sponsoring clinical trial NCT02296554?

This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02296554's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02296554, the US trial registry maintained by the National Library of Medicine. NCT02296554 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.